UPMC LITITZ — History
CCN 390068 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$115M
Latest Revenue (FY2022)
+15.2%
Revenue CAGR (3yr)
14.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $86M | $103M | $115M | +11.4% | +15.2% |
| Operating Expenses | $86M | $92M | $98M | +6.3% | +6.6% |
| Operating Margin | -0.1% | 10.1% | 14.2% | +40.5% | +0.0% |
| Net Income | $-0M | $10M | $16M | +56.5% | +0.0% |
| Licensed Beds | 36 | 46 | 36 | -21.7% | +0.0% |
| Total Patient Days | 11,425 | 15,685 | 9,423 | -39.9% | -9.2% |
| Medicare Day % | 26% | 22% | 35% | +57.6% | +16.1% |
| Medicaid Day % | 2% | 2% | 2% | +31.9% | +8.8% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +32.7% ($86M → $115M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+15.2%
This Hospital
+7.6%
State Avg
Latest Margin
14.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $129M | 21.4% |
| FY2024 (proj) | $143M | 28.6% |
| FY2025 (proj) | $157M | 35.8% |